AUS
NZ
UK
CA
USA
IND
Argosy Minerals Limited (ASX:AGY), a company focused on lithium mineral exploration, has informed the market that 600,000 unquoted Options with an exercise price of $0.7293 expired unexercised on 30 June 2026. These options, identified by the security code AGYAD, lapsed without being converted or exercised, resulting in no issuance of new ordinary shares and no cash proceeds to the company. This expiration reduces Argosy's unquoted option pool and reflects that the exercise price was significantly above market levels at expiry. Investors monitoring Argosy's Capital Structure should note the updated Issued Capital figures disclosed alongside this announcement.
Key Points
- Company: Argosy Minerals Limited (ASX:AGY)
- 600,000 unquoted options (code: AGYAD) expired unexercised on 30 June 2026
- Exercise price of expired options was $0.7293 per option
- No consideration was received by the company upon expiration
- Post-expiry, AGY ordinary shares on issue total 1,543,460,934
- Remaining quoted options (AGYO, expiring 1 August 2028) total 39,959,996
- Investors should monitor future option issuances or capital structure changes as Argosy advances its projects
Details on the 600,000 AGYAD Options and Their Expiry at $0.7293
The expired options were unquoted equity securities, meaning they were not traded on the ASX like the company's ordinary shares. Each option granted the holder the right, but not the obligation, to convert one option into one ordinary AGY share at $0.7293 on or before 30 June 2026. At expiry, holders chose not to exercise, causing the options to lapse entirely.
This non-exercise aligns with the fact that exercising at $0.7293 was not economically advantageous compared to the prevailing market price of AGY shares at that time. The company confirmed no consideration was received upon expiry and did not disclose details about the option holders or the original issuance conditions. The AGYAD options now show zero securities on issue, removing them from Argosy's capital structure.
Argosy Minerals' Capital Structure After AGYAD Option Expiry
Following the lapse of the 600,000 AGYAD options, Argosy Minerals updated its capital structure as detailed in Part 3 of the Appendix 3H filing. The company’s fully paid ordinary shares on issue stand at 1,543,460,934, which forms the basis for market capitalization calculations published by the ASX.
On the quoted options front, Argosy holds 39,959,996 options under the code AGYO, expiring on 1 August 2028. Additionally, in unquoted equity securities, the company has 10,000,000 performance rights (AGYAB) and 1,000,000 options (AGYAE) with a $0.135 exercise price expiring on 3 March 2029. The expiry of AGYAD options did not affect the ordinary share count as no conversion occurred.
Significance of the Appendix 3H Filing for AGY Investors
An Appendix 3H is an ASX regulatory form used to formally notify the exchange of securities cessation, which can result from option expiry, convertible note conversion, or security cancellation. Here, the cessation was due solely to option expiry without exercise, a straightforward lapse. This filing ensures the market maintains an accurate view of the company’s issued capital.
For AGY shareholders, this filing has minimal immediate dilution impact since no new shares were issued. However, it highlights the layers of Argosy’s capital structure, including the active AGYO quoted options expiring in August 2028 and the AGYAE unquoted options expiring in March 2029. Shareholders and potential investors should monitor these remaining options as their expiry dates approach.
Context of the $0.7293 Exercise Price in Argosy’s Option History
The $0.7293 exercise price on the expired AGYAD options is substantially higher than the $0.135 price on the still-active AGYAE options expiring in March 2029. This difference likely reflects the periods when these options were issued, with higher exercise prices generally linked to times when the company’s share price was elevated or when options were priced at a premium to market.
The contrast between the $0.7293 and $0.135 strike prices illustrates significant shifts in Argosy’s share price environment over time. The company did not disclose the original issuance date, recipients, or circumstances of the AGYAD options in this update. Investors seeking comprehensive option issuance history should consult earlier capital management disclosures and annual reports.
Remaining AGYO Quoted Options Expiring in August 2028
With AGYAD options fully lapsed, attention may turn to the 39,959,996 quoted AGYO options expiring on 1 August 2028. These ASX-quoted options can be traded on the market, providing liquidity and market-driven valuation.
If exercised before expiry, AGYO options would generate new ordinary shares and cash proceeds for Argosy. The exercise price for AGYO options was not restated in this announcement; investors should refer to prior disclosures for details. Exercise decisions will depend on Argosy’s share price relative to the strike price during the remaining term.
Performance Rights and Long-Term Incentives for Argosy Management
Argosy’s capital structure also includes 10,000,000 performance rights under code AGYAB. These are typical long-term incentives for executives and key personnel, vesting upon achievement of specific milestones or time conditions rather than a fixed exercise price.
The presence of these performance rights indicates ongoing management incentive alignment with company performance. This update did not detail vesting conditions, performance hurdles, or beneficiaries. Shareholders interested in these terms should consult Argosy’s latest meeting notices or remuneration reports, which disclose such information per ASX Listing Rules.
No Cash Impact from the Option Expiry
Since the 600,000 AGYAD options expired unexercised, Argosy received no cash proceeds. Had all been exercised at $0.7293, the company would have theoretically raised approximately $437,580, though this figure was not disclosed and is for illustration only. The expiry did not affect the company’s cash position.
For Argosy, which requires prudent capital management for ongoing projects and corporate expenses, the absence of proceeds from these lapsed options is a modest but notable outcome. Investors should continue monitoring financial disclosures, including quarterly cash flow reports and half-year or full-year financial statements, for updates on liquidity and capital resources.
Implications of the Updated Capital Table on Future Dilution Risk
With the AGYAD options extinguished, the dilutive risk from this class is removed. Remaining potential dilution arises from 39,959,996 AGYO quoted options, 1,000,000 AGYAE unquoted options at $0.135, and 10,000,000 AGYAB performance rights, totaling up to about 50,959,996 possible new shares if fully converted.
Compared to the 1,543,460,934 ordinary shares on issue, this represents a relatively small dilution proportion. However, future capital raisings, new option grants, or performance right issuances—none indicated in this update—could change this outlook. The immediate share price impact of this cessation was unclear due to the routine nature of the filing and absence of operational or financial updates.
Next Steps and Disclosure Requirements Following Securities Expiry
The Appendix 3H lodgement completes the administrative process of closing out the ceased AGYAD securities under ASX Listing Rules. Argosy has confirmed no further information or related party transactions were necessary to disclose in connection with this event.
Going forward, investors should focus on Argosy’s broader operational and strategic developments rather than this routine capital maintenance. Key areas to watch include updates on lithium project progress, capital structure changes, project financing or partnerships, and upcoming financial reports. The next significant milestone for option-related activity will be the performance of the AGYO quoted options as their August 2028 expiry approaches and whether Argosy’s share price supports their exercise.
